Dr Edward J Pollander, DDS in Andover, OH - Dentist

Dr Edward J Pollander, DDS is a Dentist - General Practice based in Andover, Ohio. Dr Edward J Pollander is licensed to practice in Ohio (license number 30-01-7464) and his current practice location is 6258 East Main St, Andover, Ohio. He can be reached at his office (for appointments etc.) via phone at (440) 293-7494.

NPI number for Dr Edward J Pollander is 1316036205 and his current mailing address is Po Box 667, Andover, Ohio. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1316036205.

Contact Information

	Dr Edward J Pollander, DDS
	6258 East Main St, Andover, OH 44003
	(440) 293-7494
	Not Available

Healthcare Provider's Profile

Full Name	Dr Edward J Pollander
Gender	Male
Speciality	Dentist - General Practice
Location	6258 East Main St, Andover, Ohio
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1316036205
Provider Enumeration Date: 10/11/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Dr Edward J Pollander such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1316036205	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1223G0001X	Dentist - General Practice	30-01-7464 (Ohio)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Edward J Pollander is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Edward J Pollander, DDS Po Box 667, Andover, OH 44003-0667 Ph: (440) 293-7494	Dr Edward J Pollander, DDS 6258 East Main St, Andover, OH 44003 Ph: (440) 293-7494

News Archive

Potential new therapy for treatment of neurodegenerative diseases

Researchers have provided new information about how communication among neurons may be prevented from deteriorating in conditions such as Alzheimer's disease (AD).

Tideswell-AGS-ADGAP ELIA program offers a new take on learning to lead for experts in geriatrics

Experts in geriatrics, the healthcare specialty dedicated to our needs as we age, are making more than a New Year's resolution to continue improving our care as we grow older.

Boehringer Ingelheim advances into Phase 3 clinical trial of BI 201335

Boehringer Ingelheim today announced a preview of the study designs for the pivotal Phase 3 clinical trials evaluating BI 201335, its investigational once-daily oral protease inhibitor, in both treatment-naive and -experienced patients with chronic genotype-1 hepatitis C virus, the most challenging genotype to treat.

GeoVax Labs provides updates on HIV-1 vaccine trials

GeoVax Labs, Inc., an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today provided an update on its vaccine trials progress.

Government dietary guidelines, unintended consequences and public policy

In the years following the government promotion of a low-fat diet, obesity in America has reached almost epidemic levels.

Dr Edward J Pollander, DDS - Dentist in Andover, OH